BRCA2 and ovarian carcinoma: Remarkably, although RTx-161 showed little to no activity as a single agent in PE01 ovarian cancer cells harboring a single BRCA2 mutant allele (BRCA2.5193 C > G), it strongly potentiated the effects of Olaparib and the combination was synergistic (Fig. 2c).